In this pilot study, the investigators will show feasibility of the NLP-based feedback
system in 20 consultations of men with newly diagnosed prostate cancer. The investigators
will recruit from the practices of up to 10 physicians who typically see these patients.
The investigators will report the top five sentences from each consultation across key
content areas (cancer prognosis, life expectancy, erectile dysfunction, urinary
incontinence, and irritative urinary symptoms) to both patients and physicians within 2
weeks of the consultation.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT05923684.
Locations matching your search criteria
United States
California
Los Angeles
Cedars Sinai Medical CenterStatus: Active
Contact: Timothy J. Daskivich
Phone: 310-423-0415
The primary research procedures are:
1. Audio recording and transcribing treatment counseling discussions for 20 men with
newly diagnosed clinically localized prostate cancers and utilize NLP to extract key
content using the system described above.
2. Reports including the top five sentences by NLP probability for key content areas
will be generated and will be provided to patients and providers within 2 weeks
after each case.
3. For patients, decisional conflict and risk perception will be assessed before and
after receiving the NLP-based feedback.
4. For physicians, the investigators will assess baseline quality of risk
communication, any changes in individual physician communication over time, and
accuracy of risk estimates for key content areas.
5. Within 2 weeks of receiving the NLP-based feedback, the investigators will conduct a
30-minute semi-structured interview with patients to obtain their opinions on the
utility and ideal implementation strategy for the NLP-based feedback.
6. At the conclusion of the pilot trial, the investigators will conduct 30-minute
semi-structured interview with counseling physicians to obtain their opinions on the
utility and ideal implementation strategy for the NLP-based feedback.
Trial PhaseNo phase specified
Trial Typehealth services research
Lead OrganizationCedars Sinai Medical Center
Principal InvestigatorTimothy J. Daskivich
